Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs

Clinical and Experimental Allergy

Volumn 34, Issue 11, 2004, Pages 1776-1783

  Mink, Steven N ^a,b   Simons, F E R ^a   Simons, K J ^a   Becker, A B ^a   Duke, K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Adrenaline; Allergy; Anaphylaxis; Distributive shock; Epinephrine; Pharmacokinetics; Vasoactive agents

Indexed keywords

ADRENALIN; RAGWEED ANTIGEN;

ADRENALIN BLOOD LEVEL; ANAPHYLACTIC SHOCK; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE;

ALLERGENS; AMBROSIA; ANAPHYLAXIS; ANIMALS; CROSS-OVER STUDIES; DISEASE MODELS, ANIMAL; DOGS; DRUG ADMINISTRATION SCHEDULE; EPINEPHRINE; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; VASOCONSTRICTOR AGENTS;

EID: 9244228965     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02106.x     Document Type: Article

References (31)

1. Atkinson TP, Kaliner MA. Anaphylaxis. Med Clin N Am 1992; 76:841-55.
2. Lieberman P. Anaphylaxis and anaphylactoid reactions. In: Adkinson NF Jr, Busse WW, Yunginger JW, Bochner BS, Holgate ST, Simons FER, eds. Middleton's allergy principles & practice, 6th edn. St Louis: Elsevier Inc., 2003; 1497-522.
3. Roizen ME, Levy J, Moss J. Anaphylactic and anaphylactoid reactions. In: Hall JB, Schmidt GA, Wood LDH, eds. Principals of critical care, 2nd edn. New York: McGraw-Hill, 1998; 1595-604.
4. Yocum MW, Butterfield JH, Klein JS, Volvcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olsmsted County: a population-based study. J Allergy Clin Immunol 1999; 104:452-6.
5. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161:15-21.
6. Nicklas RA, Bernstein IL, Li JT et al. Diagnosis and management of anaphylaxis. J Allergy Clin Immunol 1998; 101:5465-98.
7. Barach ER, Nowalk RM, Lee TG, Tomalanovich MC. Epinephrine for treatment of anaphylactic shock. J Am Med Assoc 1984; 251:2118-22.
8. Simons FER, Chad Z, Dean JM, Watson WTA. Position statement: fatal anaphylactic reactions to food in children. Can Med Assoc J 1994; 150:337-9.
9. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002; 110:647-51.
10. Orange RP, Kaliner MA, Laria PJ, Austen KF. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. Fed Proc 1971; 30:1725-8.
11. Smith PL, Kagey-Sobotka A, Blecker ER et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072-80.
12. Muelleman RI, Pribble JP, Salomone JA. Blood pressure effects of thyrotropin releasing hormone and epinephrine in anaphylactic shock. Ann Emerg Med 1988; 17:309-13.
13. Mink SN, Bands C, Becker A et al. Effect of bolus epinephrine on systemic hemodynamics in canine anaphylactic shock. Cardiovasc Res 1998; 40:546-56.
14. Bautista E, Simons FER, Simons KJ et al. Epinephrine fails to hasten hemodyanmic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002; 128:151-64.
15. National Institutes of Health. Guide for the care and use of laboratory animals (NIH Publications 85-23). Bethesda, MD: National Institutes of Health, 1996.
16. Kepron W, Jackson C, Sehon A. A canine model for the study of hapten-specific suppression of IgE-mediated bronchoconstriction in anaphylaxis. Int Arch Allergy Appl Immunol 1987; 82:468-70.
17. Kepron W, James J, Kirk B, Sehon A, Tse K. A canine model for reaginic hypersensitivity and allergic bronchoconstriction. J Allergy Clin Immunol 1977; 59:64-9.
18. Frederiksen M, Henthorn T, Ruo T, Atkinson A. Pharmacokinetics of pentobarbital in dogs. J Pharmacol Exp Ther 1983; 225:355-60.
19. Unruh H, Wang R, Bose D, Mink S. Does pentobarbital anesthesia depress left ventricular contractility in dogs? Am J Physiol (Heart Circ Physiol 30) 1991; 261:H700-6.
20. Correa E, Mink S, Unruh H, Kepron W. Left ventricular contractility is depressed in IgE-mediated anaphylactic shock in dogs. Am J Physiol (Heart Circ Physiol 29) 1991; 260:H744-51.
21. Simons FER, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with history of anaphylaxis. J Allergy Clin Immunol 1998; 101:33-7.
22. Hijemdahl P. Plasma catecholamines-analytical challenges and physiological limitations. Baillieres Clin Endocrinol Metab 1993; 7:307-53.
23. Huffman BB. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilmans's the pharmacological basis of therapeutics, 10th edn. New York: McGraw-Hill, 2001; 215-68.
24. Bautista E, Duke K, Becker A et al. Effects of repetitive allergen challenges on hemodynamics and epinephrine response in anaphylactic shock in dogs. Am J Respir Crit Care Med 2001; 163:A136.
25. Austen KR. Systemic anaphylaxis in the human lung. N Engl J Med 1974; 291:661-4.
26. Kaliner M, Orange RP, Austen KF. Immunological release of histamine and slow reacting substance of anaphylaxis form human lung. IV. Enhancement by cholinergic and alpha adrenergic stimulation. J Exp Med 1972; 136:556-67.
27. Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults. J Allergy Clin Immunol 2001; 108:871-3.
28. Bailey PL, Stanley TH. Intravenous opiod anesthetics. In: Miller RF, ed. Anesthesia. New York: Churchill Livingstone, 1994: 291-387.
29. Pisko E, Weniger F, DeGroat WC. The effect of halothane on preganglionic and postganglionic sympathetic activity in the cat. Brain Res 1970; 20:330-4.
30. Chrusch C, Sharma S, Unruh H et al. Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis. Am J Respir Crit Care Med 1999; 160:1142-9.
31. Wagner EM, Mitzner WA, Bleeker ER. Peripheral circulatory alterations in canine anaphylactic shock. Am J Physiol (Heart Circ Physiol 20) 1986; 251:H934-40.